Viva Biotech Holdings Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	520	226	260	402	1,020	1,844
Market Cap Growth	145.71%	-13.23%	-35.25%	-60.56%	-44.70%	126.37%
Enterprise Value	552	295	490	697	1,183	1,683
Last Close Price	0.24	0.10	0.11	0.20	0.50	0.89
PE Ratio	25.41	10.21	-	-	25.63	-
PS Ratio	2.38	0.86	0.95	1.25	3.50	21.13
PB Ratio	1.12	0.45	0.55	0.82	1.88	3.92
P/TBV Ratio	3.13	1.33	1.84	3.05	6.01	10.23
P/FCF Ratio	20.42	9.32	10.43	21.69	-	-
P/OCF Ratio	12.45	4.57	5.32	7.68	94.67	341.11
EV/Sales Ratio	2.53	1.12	1.78	2.16	4.06	19.28
EV/EBITDA Ratio	10.41	5.16	9.81	11.78	23.11	81.76
EV/EBIT Ratio	20.33	9.71	19.92	19.32	36.09	119.41
EV/FCF Ratio	21.67	12.17	19.61	37.58	-	-
Debt / Equity Ratio	0.30	0.34	0.52	0.78	0.68	0.79
Debt / EBITDA Ratio	2.59	2.90	4.71	6.25	6.81	16.25
Debt / FCF Ratio	5.39	7.01	9.72	20.65	-	-
Net Debt / Equity Ratio	0.06	0.09	0.24	0.60	0.47	0.16
Net Debt / EBITDA Ratio	0.58	0.79	2.22	4.91	5.01	3.72
Net Debt / FCF Ratio	1.18	1.87	4.43	15.68	-3.80	-1.11
Asset Turnover	0.26	0.27	0.28	0.30	0.26	0.14
Inventory Turnover	4.24	4.88	4.84	5.61	7.33	4.53
Quick Ratio	1.22	1.26	1.03	0.44	1.44	3.75
Current Ratio	1.76	1.67	1.32	0.73	2.14	4.56
Return on Equity (ROE)	5.87%	5.92%	-2.74%	-13.41%	7.84%	-13.69%
Return on Assets (ROA)	2.03%	1.98%	1.57%	2.08%	1.83%	1.40%
Return on Invested Capital (ROIC)	4.41%	3.96%	3.74%	4.62%	4.04%	4.28%
Return on Capital Employed (ROCE)	3.90%	3.90%	3.30%	5.10%	3.30%	1.50%
Earnings Yield	3.94%	9.80%	-5.69%	-17.82%	3.90%	-2.63%
FCF Yield	4.90%	10.73%	9.59%	4.61%	-6.61%	-3.73%
Dividend Yield	-	-	-	-	-	0.33%
Payout Ratio	-	-	-	-	5.66%	-
Buyback Yield / Dilution	-48.61%	-41.39%	-5.91%	2.81%	-25.41%	-5.83%
Total Shareholder Return	-48.61%	-41.39%	-5.91%	2.81%	-25.41%	-5.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.